205 related articles for article (PubMed ID: 19485917)
21. The cardioprotective effects of statins.
Eto M; Lüscher TF
Coron Artery Dis; 2004 Aug; 15(5):243-5. PubMed ID: 15238819
[TBL] [Abstract][Full Text] [Related]
22. Models for describing relations among the various statin drugs, low-density lipoprotein cholesterol lowering, pleiotropic effects, and cardiovascular risk.
Robinson JG
Am J Cardiol; 2008 Apr; 101(7):1009-15. PubMed ID: 18359323
[TBL] [Abstract][Full Text] [Related]
23. Vascular effects of HMG CoA-reductase inhibitors (statins) unrelated to cholesterol lowering: new concepts for cardiovascular disease.
Lefer AM; Scalia R; Lefer DJ
Cardiovasc Res; 2001 Feb; 49(2):281-7. PubMed ID: 11164838
[No Abstract] [Full Text] [Related]
24. Pluripotential mechanisms of cardioprotection with HMG-CoA reductase inhibitor therapy.
Rosenson RS
Am J Cardiovasc Drugs; 2001; 1(6):411-20. PubMed ID: 14728000
[TBL] [Abstract][Full Text] [Related]
25. [The role of HMG-CoA reductase inhibitors in regulation of the inflammatory processes].
Cecha J; Drabek G; Błazelonis A; Romanowski W; Zubelewicz-Szkodzińska B
Wiad Lek; 2004; 57(5-6):255-8. PubMed ID: 15518071
[TBL] [Abstract][Full Text] [Related]
26. Pleiotropic effects of statins: evidence for benefits beyond LDL-cholesterol lowering.
Marzilli M
Am J Cardiovasc Drugs; 2010; 10 Suppl 1():3-9. PubMed ID: 21391728
[TBL] [Abstract][Full Text] [Related]
27. Intermolecular differences of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors contribute to distinct pharmacologic and pleiotropic actions.
Mason RP; Walter MF; Day CA; Jacob RF
Am J Cardiol; 2005 Sep; 96(5A):11F-23F. PubMed ID: 16126019
[TBL] [Abstract][Full Text] [Related]
28. Antioxidant effects of statins.
Stoll LL; McCormick ML; Denning GM; Weintraub NL
Timely Top Med Cardiovasc Dis; 2005 Feb; 9():E1. PubMed ID: 15824760
[TBL] [Abstract][Full Text] [Related]
29. [Pleiotropic effects of statins on endothelium and signaling mechanisms].
Shiota M; Izumi Y; Nakao T; Iwao H
Nihon Yakurigaku Zasshi; 2006 Sep; 128(3):161-6. PubMed ID: 16971779
[No Abstract] [Full Text] [Related]
30. Statins and cardioprotection--more than just lipid lowering?
Ludman A; Venugopal V; Yellon DM; Hausenloy DJ
Pharmacol Ther; 2009 Apr; 122(1):30-43. PubMed ID: 19318042
[TBL] [Abstract][Full Text] [Related]
31. HMG-CoA reductase inhibitors decrease CD11b expression and CD11b-dependent adhesion of monocytes to endothelium and reduce increased adhesiveness of monocytes isolated from patients with hypercholesterolemia.
Weber C; Erl W; Weber KS; Weber PC
J Am Coll Cardiol; 1997 Nov; 30(5):1212-7. PubMed ID: 9350917
[TBL] [Abstract][Full Text] [Related]
32. Antioxidant effects of statins.
Stoll LL; McCormick ML; Denning GM; Weintraub NL
Drugs Today (Barc); 2004 Dec; 40(12):975-90. PubMed ID: 15645009
[TBL] [Abstract][Full Text] [Related]
33. Beyond lipid-lowering: effects of statins on endothelial nitric oxide.
Laufs U
Eur J Clin Pharmacol; 2003 Mar; 58(11):719-31. PubMed ID: 12634978
[TBL] [Abstract][Full Text] [Related]
34. Pleiotropic Effects of Statins on the Cardiovascular System.
Oesterle A; Laufs U; Liao JK
Circ Res; 2017 Jan; 120(1):229-243. PubMed ID: 28057795
[TBL] [Abstract][Full Text] [Related]
35. Translating the effects of statins: from redox regulation to suppression of vascular wall inflammation.
Antonopoulos AS; Margaritis M; Shirodaria C; Antoniades C
Thromb Haemost; 2012 Nov; 108(5):840-8. PubMed ID: 22872079
[TBL] [Abstract][Full Text] [Related]
36. Potential vascular benefits of statins.
Kinlay S
Am J Med; 2005 Dec; 118 Suppl 12A():62-7. PubMed ID: 16356810
[TBL] [Abstract][Full Text] [Related]
37. Role of endothelial nitric oxide synthase and vagal activity in the endothelial protection of atorvastatin in ischemia/reperfusion injury.
Bi XY; He X; Zhao M; Yu XJ; Zang WJ
J Cardiovasc Pharmacol; 2013 May; 61(5):391-400. PubMed ID: 23364605
[TBL] [Abstract][Full Text] [Related]
38. The endothelial-protective effects of HMG-CoA reductase inhibition in the setting of ischemia and reperfusion injury.
Liuni A; Luca MC; Gori T; Parker JD
Clin Hemorheol Microcirc; 2010; 45(2-4):161-7. PubMed ID: 20675896
[TBL] [Abstract][Full Text] [Related]
39. Endothelium-dependent effects of statins.
Wolfrum S; Jensen KS; Liao JK
Arterioscler Thromb Vasc Biol; 2003 May; 23(5):729-36. PubMed ID: 12615672
[TBL] [Abstract][Full Text] [Related]
40. Effects of HMG-CoA reductase inhibitors on endothelial function: role of microdomains and oxidative stress.
Mason RP; Walter MF; Jacob RF
Circulation; 2004 Jun; 109(21 Suppl 1):II34-41. PubMed ID: 15173061
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]